Long Acting Self Administered HIV Therapy with CCR5 Antibody PRO 140

Grant

Date/time Interval

  • May 1, 2014 - April 30, 2015

    • Awarded By

    Total Award Amount

  • 5647.00

    • Direct Costs

  • 3842.00

    • Sponsor Award Id

  • 220603_UAB

    • Contributor

  • Edward Acosta Pharm.D.   Principal Investigator